Skip to main content

Table 5 Survival analysis for patients presenting with regional disease

From: Demographics, clinical features, and prognosis of rare lymphoepithelioma-like carcinoma across different anatomic sites

Site

Unadjusted model: crude hazard ratio (95% CI)

P

Model 1a: hazard ratio (95% CI)

P

Nasopharynx

1

Ref

1

Ref

Salivary gland

1.07 (0.75–1.53)

0.713

1.02 (0.68–1.52)

0.937

Tonsil

1.01 (0.75–1.37)

0.923

1.22 (0.88–1.69)

0.233

Lung and bronchus

1.71 (1.05–2.80)

0.031

1.72 (1.03–2.88)

0.038

Urinary bladder

1.96 (1.19–3.20)

0.008

1.62 (0.95–2.76)

0.075

Female genital system

0.67 (0.28–1.63)

0.383

1.09 (0.439–2.73)

0.084

Digestive system

2.03 (1.01–4.1)

0.048

2.05 (0.99–4.23)

0.051

  1. Abbreviations: CI confidence interval, Ref reference group
  2. aModel 1: Full model. Adjusted by year of diagnosis, age (continuous variable), sex, race, grade, and treatment